APA (7th ed.) Citation

Di Luigi, L., Corinaldesi, C., Colletti, M., Scolletta, S., Antinozzi, C., Vannelli, G. B., . . . Crescioli, C. (2016). Phosphodiesterase Type 5 Inhibitor Sildenafil Decreases the Proinflammatory Chemokine CXCL10 in Human Cardiomyocytes and in Subjects with Diabetic Cardiomyopathy. Inflammation, 39(3), 1238-1252. https://doi.org/10.1007/s10753-016-0359-6

Chicago Style (17th ed.) Citation

Di Luigi, Luigi, et al. "Phosphodiesterase Type 5 Inhibitor Sildenafil Decreases the Proinflammatory Chemokine CXCL10 in Human Cardiomyocytes and in Subjects with Diabetic Cardiomyopathy." Inflammation 39, no. 3 (2016): 1238-1252. https://doi.org/10.1007/s10753-016-0359-6.

MLA (9th ed.) Citation

Di Luigi, Luigi, et al. "Phosphodiesterase Type 5 Inhibitor Sildenafil Decreases the Proinflammatory Chemokine CXCL10 in Human Cardiomyocytes and in Subjects with Diabetic Cardiomyopathy." Inflammation, vol. 39, no. 3, 2016, pp. 1238-1252, https://doi.org/10.1007/s10753-016-0359-6.